3rd Peptides Conference

The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy for treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.

SMi’s CPD-certified conference provides the perfect platform to discuss the latest innovations in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and novel technologies for development and improvement.

Plus 2 interactive pre-conference workshops:
A: Cyclic Peptides - Discovery, Development and Deployment
B: Cupid Cell-Penetrating Peptides - a powerful new tool for cellular research

Early Bird Discounts:
Book by 31st March and save £500.
Book by 29th April and save £300.
Book by 27th May and save £200.